Navigation Links
PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Shares and Corrects Ex-Dividend Trading Date for Common Shares
Date:2/7/2008

PEMBROKE, Bermuda, Feb. 7 /PRNewswire-FirstCall/ -- PartnerRe Ltd. (NYSE: PRE) announced that its Board of Directors has declared a dividend for the period December 1, 2007 - February 29, 2008 of $0.421875 per share on the Company's 6.75% Series C Cumulative Redeemable Preferred Shares, and $0.40625 per share on the Company's 6.5% Series D Cumulative Redeemable Preferred Shares. The dividends will be payable on March 3, 2008, to shareholders of record on February 22, 2008.

PartnerRe Ltd. is a leading global reinsurer, providing multi-line reinsurance to insurance companies. The Company, through its wholly owned subsidiaries, also offers alternative risk products that include weather and credit protection to financial, industrial and service companies. Risks reinsured include property, casualty, motor, agriculture, aviation/space, catastrophe, credit/surety, engineering, energy, marine, specialty property, specialty casualty, multiline and other lines, life/annuity and health, and alternative risk products. For the year ended December 31, 2007, total revenues were $4.2 billion, total assets were $16.0 billion, and at December 31, 2007 total capital was $5.2 billion and total shareholders' equity was $4.3 billion.

PartnerRe on the Internet: http://www.partnerre.com

Contacts: PartnerRe Ltd. Sard Verbinnen & Co.

(441) 292-0888 (212) 687-8080

Investor Contact: Robin Sidders Drew Brown/Jane Simmons

Media Contact: Celia Powell


'/>"/>
SOURCE PartnerRe Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend
4. Mylan Declares Quarterly Preferred Stock Dividend
5. NHP Increases Its Quarterly Common Dividend by $0.03 and Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
6. BD Board Declares Dividend
7. Assurant Board of Directors Declares Quarterly Dividend of $0.12 per Share
8. Wyeth Declares Common and Preferred Stock Dividends
9. STERIS Corporation Declares Regular Quarterly Dividend
10. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
11. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 22, 2017 , ... Patients who avoid necessary dental and endodontic treatments because ... Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists offer three ... more sedation methods may be recommended based on the severity of the anxiety experienced ...
(Date:5/22/2017)... , ... May 22, 2017 , ... An inventor from ... with a pen. "My wife’s hand was damaged in a firework accident, so she ... helps people with manual problems." , He then designed and created a prototype for ...
(Date:5/22/2017)... ... May 22, 2017 , ... Faithfully following pop culture, people today are ... toned and shaped through fitness programs. It carries on to skin nourished, pampered and ... an irresistible, radiant smile. CDA has found that just like a perfectly ...
(Date:5/21/2017)... ... , ... Chris Cornell, 52, was found dead on the night of Wednesday, May 17, 2017. ... singers in the rock industry would take his own life, but the extremely talented and ... illness played a role in the death of Chris Cornell . , Depression and ...
(Date:5/21/2017)... Viejo, CA (PRWEB) , ... May 20, 2017 ... ... self-animating, paragraph styled corporate text designs created specifically for use in Final Cut ... editing process for all media productions. Pixel Film Studios’ ProParagraph Corporate will deliver ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: